SPHK1 and rheumatoid arthritis: Together, these studies suggest that increased levels of S1P via SPHK1 contributes a primary role in the progression of inflammatory arthritis, and SPHK1 modulation may provide a novel approach to treating autoimmune conditions such as RA.